November 21, 2024
As immuno-oncology continues to grow as a therapeutic area, more preclinical research is driven towards assessing immunotherapeutics as single agent or combination therapies. This requires the use of immunocompetent models, a variety of which exist across both mouse analogue and human specific platforms. As each model has their own pros and cons, choosing exactly which one is the most appropriate for a study can prove difficult.
This White Paper covers the main immunocompetent model types with their features, limitations, and major uses, to help select the best model for any given immuno-oncology study.
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2023-06-09
2017-07-18
landing_page
PDX/Databases